Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antje Prasse

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Deutsche Medizinische Wochenschrift (1946)|June 1, 2017
[Sarcoidosis - Recent Advances]Antje Prasse
Deutsches Arzteblatt International|March 18, 2017
In ReplyAntje Prasse
Chest|August 10, 2019
POINT: Should Molecular and Genetic Biomarkers Be Used in the Initial Evaluation of Patients With Fibrotic ILD? YesAntje Prasse
Chest|August 10, 2019
Rebuttal From Dr PrasseAntje Prasse
Deutsches Arzteblatt International|September 7, 2016
The Diagnosis, Differential Diagnosis, and Treatment of SarcoidosisAntje Prasse
Internal and Emergency Medicine|January 5, 2018
Sarcoidosis: a review for the internistElena Bargagli, Antje Prasse
Respiration; International Review of Thoracic Diseases|December 3, 2020
Immunomodulation in Autoimmune Interstitial Lung DiseaseBenjamin Seeliger, Antje Prasse
Respirology (Carlton, Vic.)|August 26, 2009
Non-invasive biomarkers in pulmonary fibrosisAntje Prasse, Joachim Müller-Quernheim
Current Opinion in Pulmonary Medicine|July 25, 2013
Common variable immunodeficiency-associated granulomatous and interstitial lung diseaseAntje Prasse, Gian Kayser, Klaus Warnatz
Deutsche Medizinische Wochenschrift (1946)|June 26, 2023
[An outline of pulmonary hemorrhage - A pulmonologists perspective]Jannik Ruwisch, Tobias Welte, Antje Prasse
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Deutsche Medizinische Wochenschrift (1946)|June 1, 2017
[Sarcoidosis - Recent Advances]Antje Prasse
Deutsches Arzteblatt International|March 18, 2017
In ReplyAntje Prasse
Chest|August 10, 2019
POINT: Should Molecular and Genetic Biomarkers Be Used in the Initial Evaluation of Patients With Fibrotic ILD? YesAntje Prasse
Chest|August 10, 2019
Rebuttal From Dr PrasseAntje Prasse
Deutsches Arzteblatt International|September 7, 2016
The Diagnosis, Differential Diagnosis, and Treatment of SarcoidosisAntje Prasse
Internal and Emergency Medicine|January 5, 2018
Sarcoidosis: a review for the internistElena Bargagli, Antje Prasse
Respiration; International Review of Thoracic Diseases|December 3, 2020
Immunomodulation in Autoimmune Interstitial Lung DiseaseBenjamin Seeliger, Antje Prasse
Respirology (Carlton, Vic.)|August 26, 2009
Non-invasive biomarkers in pulmonary fibrosisAntje Prasse, Joachim Müller-Quernheim
Current Opinion in Pulmonary Medicine|July 25, 2013
Common variable immunodeficiency-associated granulomatous and interstitial lung diseaseAntje Prasse, Gian Kayser, Klaus Warnatz
Deutsche Medizinische Wochenschrift (1946)|June 26, 2023
[An outline of pulmonary hemorrhage - A pulmonologists perspective]Jannik Ruwisch, Tobias Welte, Antje Prasse
Pageof 16